Literature DB >> 20717690

Conversion disorder as initial diagnosis in pantothenate kinase associated neurodegeneration.

I Vansteenkiste, W A van Gool, D J Hofstee, Marina A J Tijssen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20717690     DOI： 10.1007/s00415-010-5688-z

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.

Authors:  B Zhou; S K Westaway; B Levinson; M A Johnson; J Gitschier; S J Hayflick
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

2.  Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.

Authors:  S J Hayflick; M Hartman; J Coryell; J Gitschier; H Rowley
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

3.  Atypical Hallervorden-Spatz disease with preserved cognition and obtrusive obsessions and compulsions.

Authors:  Anthony P Nicholas; Kelly S Earnst; Daniel C Marson
Journal:  Mov Disord       Date:  2005-07       Impact factor: 10.338

4.  The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration.

Authors:  M T Pellecchia; E M Valente; L Cif; S Salvi; A Albanese; V Scarano; U Bonuccelli; A R Bentivoglio; A D'Amico; C Marelli; A Di Giorgio; P Coubes; P Barone; B Dallapiccola
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

Review 5.  Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.

Authors:  Susan J Hayflick
Journal:  Curr Opin Pediatr       Date:  2003-12       Impact factor: 2.856

6.  Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.

Authors:  Susan J Hayflick; Shawn K Westaway; Barbara Levinson; Bing Zhou; Monique A Johnson; Katherine H L Ching; Jane Gitschier
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

7.  [Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome)].

Authors:  F J Carod-Artal; A P Vargas; P B Marinho; T V Fernandes-Silva; D Portugal
Journal:  Rev Neurol       Date:  2004 Feb 16-29       Impact factor: 0.870

8.  Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.

Authors:  Madhavi Thomas; Susan J Hayflick; Joseph Jankovic
Journal:  Mov Disord       Date:  2004-01       Impact factor: 10.338

9.  Psychotic disorder in a case with Hallervorden-Spatz disease.

Authors:  O Oner; P Oner; G Deda; D Içağasioğlu
Journal:  Acta Psychiatr Scand       Date:  2003-11       Impact factor: 6.392
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.